active medical device entrepreneur and investor and Co-founder, 3DM Inc, email@example.com
Our evolving healthcare system is predicated on innovating new procedures and products to maximize the benefits to patient and society. Yet each specialty in medicine is a complex mix of current therapies, imperfect products, changing regulatory hurdles and reimbursement limitations. What are the critical success factors for innovations to reach the bedside and maximize clinical impact? How can physicians and researchers map current therapies and innovations that can reach broad adoption amid the economic challenges of our healthcare system?
This Forum will lend general summary of the process, best practices and pitfalls in clinical innovation and the commercialization process. An interactive panel discussion will include case studies and perspectives from the clinician inventor, entrepreneur, venture capital investor and corporate licensee.
Panel moderator: Richard Anders, Managing Director, Rubin/Anders Scientific, Inc., firstname.lastname@example.org
Robert Creeden, Director, Partners Research Ventures, email@example.com
David Milne, General Partner, SV Life Sciences Advisers, firstname.lastname@example.org
Thomas Stossel, MD, American Cancer Society Professor, Department of Medicine, Harvard Medical School, Co-Director, Division of Hematology, Brigham and Women's Hospital, email@example.com